Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Matter of Time

Refreshing some news here: $CLARUS THERAPEUTICS HLDGS INC(CRXT.US)$ Institutional investors and hedge funds increased their positions in the 4th quarter. Powell Investment Advisors increased its stake in shares of Clarus Therapeutics by 48.8%. Telemetry Investments purchased additional shares valued at $240,000. UBS acquired shares valued at $206,000. Schonfeld purchased shares valued at about $51,000. Citadel acquired more shares valued at about $31,000. Institutional investors own about 20% of the company’s stock.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
+0
1
Translate
Report
11K Views
Comment
Sign in to post a comment
I love this stuff
315Followers
40Following
2251Visitors
Follow